In Investing RAD receives IND approval from US FDA for Betabart (RV-01) July 28, 2025 No Comments Radiopharm Theranostics (RAD:AU) has announced RAD receives IND approval from US FDA for Betabart (RV-01) Download the PDF here. This post appeared first on investingnews.com 0 Author admin Website Related Posts Crypto Market Update: Americans Still Uninterested in Crypto Despite Institutional Support July 28, 2025 Radiopharm Theranostics Receives IND approval from US FDA to Initiate Phase I Therapeutic Clinical Study to target B7H3 with Betabart July 28, 2025 Allied Critical Metals Launches Allied USA to Expand Tungsten Import and Distribution Operations, Lists on OTCQB, and Receives DTC Eligibility July 28, 2025
Crypto Market Update: Americans Still Uninterested in Crypto Despite Institutional Support July 28, 2025
Radiopharm Theranostics Receives IND approval from US FDA to Initiate Phase I Therapeutic Clinical Study to target B7H3 with Betabart July 28, 2025
Allied Critical Metals Launches Allied USA to Expand Tungsten Import and Distribution Operations, Lists on OTCQB, and Receives DTC Eligibility July 28, 2025